HIF1A and pachyonychia congenita: And the ceRNA axes PVT1/miR-448/SERBP1 (202), PVT1/miR-519d-3p/HIF-1α (203), and PVT1/miR-143/HIF-1α (204) might also be potential biomarkers and therapeutic targets for PC.